Skip to main content

Main menu

  • Home
  • Our journals
    • Clinical Medicine
    • Future Healthcare Journal
  • Subject collections
  • About the RCP
  • Contact us

Future Healthcare Journal

  • FHJ Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Author guidance
    • Instructions for authors
    • Submit online
  • About FHJ
    • Scope
    • Editorial board
    • Policies
    • Information for reviewers
    • Advertising

User menu

  • Log in

Search

  • Advanced search
RCP Journals
Home
  • Log in
  • Home
  • Our journals
    • Clinical Medicine
    • Future Healthcare Journal
  • Subject collections
  • About the RCP
  • Contact us
Advanced

Future Healthcare Journal

futurehosp Logo
  • FHJ Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Author guidance
    • Instructions for authors
    • Submit online
  • About FHJ
    • Scope
    • Editorial board
    • Policies
    • Information for reviewers
    • Advertising

Are conflict of interest declarations appropriate to allow sufficient consideration of potential bias in presentations?

William Crawford, C Fielder Camm, Ishika Prachee, Jack Olivarius-McAllister, Matthew R Ginks and Edward D Nicol
Download PDF
DOI: https://doi.org/10.7861/fhj.2020-0018
Future Healthc J October 2020
William Crawford
AUniversity of Oxford, Oxford, UK
*authors are joint first co-authors
Roles: medical student
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C Fielder Camm
BRoyal Berkshire Hospital, Reading, UK
*authors are joint first co-authors
Roles: cardiology registrar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: christian.camm@cardiov.ox.ac.uk
Ishika Prachee
AUniversity of Oxford, Oxford, UK
Roles: medical student
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jack Olivarius-McAllister
AUniversity of Oxford, Oxford, UK
Roles: medical student
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew R Ginks
COxford University Hospitals NHS Foundation Trust, Oxford, UK
Roles: consultant cardiologist
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edward D Nicol
DRoyal Brompton Hospital, London, UK and honorary senior lecturer, National Heart and Lung Institute, London, UK
Roles: consultant cardiologist
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

ABSTRACT

Background Potential conflicts of interest (CoI) are common in medical research, necessitating the use of CoI declarations. There is currently no consensus document or external authority guiding CoI declarations in conference settings, resulting in declarations of variable quality and utility.

Methods We explored four CoI declaration parameters (sufficient slide display time; the presence of any verbal explanation pertaining to relevant CoI; the use of an adequate font size; and whether the nature and relevance of the CoI was described). Parameters were graded from one to three points, with the sum of parameters providing an overall declaration quality out of 12. We then applied this scoring system to recordings of presentations from the British Cardiovascular Society (BCS) annual conference 2018 which were available online.

Results Sixty-nine presentations were suitable for inclusion, of which 47 (68%) contained a CoI statement. Thirty-six of the 47 (77%) presentations declared that they had no CoI. In the remaining 11 (23%) with reported CoI, the median time spent displaying CoI was 1 second (interquartile range (IQR) 0.7–3.3). The median quality score for presentations was 7 (IQR 6–10).

Conclusion This study demonstrates utility in considering aspects of CoI declarations at conferences to improve transparency.

KEYWORDS
  • Conflicts of interest
  • disclosure
  • medical education

Introduction

Industry involvement is common within medical research, producing potential conflicts of interest (CoI).1 Industry interaction and CoI are associated with inappropriate prescribing, disproportionate publication of outcomes that favour sponsors, and poor research methodology.2–4 Potential CoI are particularly common in cardiology.5

Recent initiatives have been introduced in an attempt to increase transparency between clinicians and industry partners, such as the Physician Payments Sunshine Act in the USA, the Disclosure UK database and the adoption of the standardised International Committee of Medical Journal Editors form, used by many journals.6–8

Conference presentations are an important medium for communicating medical research. Despite advances made in the publishing world, there is currently no external authority or consensus document to guide how CoI declarations are presented at medical conferences.

Previous studies have demonstrated that a large proportion of conference presentations do not contain CoI declarations, or that declarations are displayed for too short a time period to be read or understood.9,10 Although many conferences have made CoI declaration slides compulsory, declarations are often brief and therefore of debateable value.10 As far as we are aware, there has been no specific analysis of the quality of CoI declarations, such as time spent making declarations with respect to the number of words presented on the CoI slide. Analysis of further quality factors, such as font readability and the presence of verbal explanation are also lacking from other studies.

This pilot study aimed to investigate the overall quality of CoI declarations in a UK cardiology conference setting; specifically, to determine whether cardiologists at a national conference in the UK are presenting their potential CoI so that they can be appropriately understood by conference attendees.

Methods

Data

Recordings of presentations from the British Cardiovascular Society (BCS) annual conference 2018 were available through the BCS website. Presentations were excluded if they were opening/closing sessions, award presentations, motivational talks from non-medical speakers or if slides were unavailable. Presentations were reviewed; time taken to declare potential CoI, the number of words present on the declaration slide and the presence of any accompanying verbal explanation were all noted. The font size used to declare potential conflicts was determined by calculating the height of capitalised letter as a percentage of the overall slide height, controlling for aspect ratios. Font sizes were expressed as point size relative to the default BCS declaration font, which was calculated as a percentage of the overall slide height, and arbitrarily assigned a value of 28 pt. Presenters without a CoI declaration were cross-referenced with The Association of the British Pharmaceutical Industry (ABPI) Disclosure UK database to determine whether any payments had been disclosed through this database.

Quality score

A 12-point metric was developed to quantify the quality of declaration statements. Points were awarded in four categories; including the presence of a verbal explanation, the level of detail provided, whether the declaration slide was displayed for an appropriate amount of time and whether the font size used was appropriate (Table 1). Zero to three points were allocated for each of these declaration characteristics.

View this table:
  • View inline
  • View popup
Table 1.

Scoring metric used to quantify quality of conflict of interest declarations in a conference setting

Statistical analysis

Results were analysed using SAS 9.3 (SAS Institute, Cary, USA). Frequencies are presented as n (%) and continuous variables as median (interquartile range (IQR)).

Results

Declarations at BCS

Eighty-four presentations were available for review. Of these, 68 met the inclusion criteria. Of these 68, 47 (69%) presentations contained a CoI statement; 22 presentations (47%) provided declarations on the title slide, while 26 (55%) provided declarations on a dedicated slide (one presentation provided declarations on both slides). Twenty-one (31%) of presentations meeting the inclusion criteria did not provide a statement outlining whether they had any CoI present (Fig 1). Of the 21 individuals without a CoI statement on their presentation, 11 (52%) had some industry payment recorded on the ABPI Disclosure UK database occurring in 2018 or earlier.

Fig 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig 1.

Flowchart detailing selection of included presentations for this analysis.

Of those with a CoI statement, 36 presentations declared that they had no CoI (77%). Of those with reported CoI (n=11; 23%), the median number of conflicts was 4 (IQR 3–13).

Overall disclosure quality

Twenty-one presentations had no CoI disclosure slide and thus had a quality metric score of 0. Of those with CoI statements, the median score was 9 (IQR 7–11). In presentations without a declared CoI, the median score was 9.5 (IQR 8–11.25). In presentations with a declared CoI, the median score was 7 (IQR 6–9.5). Two presentations with CoI (18%) scored a maximum possible 12 points, while one presentation scored 5 points.

Time spent on declarations

In those without declared conflicts, presenters spent a median of 6 seconds on the declaration slide (n=35; IQR 2–14). In those with conflicts, the median duration was 10 seconds (n=12; IQR 4–20) and the median time per conflict was 1 second (IQR 0.7–3.3). There was a median of 19 words on declaration sides in presenters with reported CoI (IQR 8–37). The median reading speed required to completely read the declaration statements of presenters with stated conflicts was 0.3 seconds per word (IQR 0.2–1.1). Three of the 11 presenters (27%) with reported conflicts displayed their declaration statement for a time such that the average reader could not completely read it.11 The median reading speed required to completely read the declaration statements of presenters without stated conflicts was 0.9 seconds per word (IQR 0.5–2.9). Two of the 36 presenters (6%) without reported conflicts displayed their declaration statement for a time such that the average reader could not completely read it.

Verbal declarations

Of those declaring no CoI, only 21/36 (58%) made any reference to the declaration. One presenter stated they had no CoI on the declaration slide but verbally reported that they had received travel reimbursement. Of those with reported CoI, five (45%) provided no verbal explanation or only stated that ‘these are my conflicts/disclosures’.

Font size

The mean font size used in CoI declarations was 94.8% (standard deviation (SD) 25.4) of the default BCS font. This equates to an average font size of approximately 26 pt, compared with the conference's default size of 28 pt. When a CoI was not present, the average font size used was 98.8% (SD 27.3) of the default, equating to size 27.5 pt font. When a CoI was present, the average font size used was 84.9% (SD 17.4) of the default, equating to size 23 pt font. Six presentations with relevant CoI used a font size less than 24 pt.

Discussion

CoI declarations are an essential tool to improve research transparency, allowing audiences to determine whether specific factors may increase the likelihood of bias. At the conference analysed in this pilot study, a large proportion (31%) of presentations did not include a CoI declaration. Of those with CoI declarations presented, a quarter reported potential conflicts. A minority of this subset appropriately declared their CoI, with only two presentations receiving full marks on the quality metric.

The merit of compulsory conflict declarations

This study demonstrates that CoI declarations are not consistently present in conference presentations. Interestingly, we observed half of presenters without a CoI declaration had recorded payments on the ABPI Disclosure UK database. This suggests there are a proportion of CoIs which go unreported.

The lack of consistency regarding CoI disclosures has been echoed by other studies. Grey et al analysed presentations from five conferences representing various specialties (one of which was a cardiovascular-themed conference), and demonstrated that only 71% of presentations contained a CoI declaration.9 CoI statements were present in 95% of the talks given at the European Society of Cardiology Annual Congress 2016, a large international conference. This conference mandates that CoI declarations are compulsory for all presenters.10 This finding suggests that mandating inclusion of a CoI slide may improve the proportion of presenters providing a description of their potential conflicts.

Improving the quality of conflict declarations

Presenters with conflicts spent a median of 10 seconds on their declaration slides. While this may appear substantial, the median time per conflict was only 1 second. Furthermore, approximately one-quarter of presenters with a conflict did not display their declaration for long enough for the average person to read the statement. This severely reduces the utility of the CoI declaration. Presentations included in our study spent more time declaring CoI than in other conferences. Previous data have demonstrated that presenters with any conflict spent median time of 2–3 seconds their CoI slide.9,10 The assessment of time-per-word is an important addition to the literature on CoI statements. Time spent on the declaration slide is a proxy to establish whether the viewer has enough time to evaluate potential conflicts. However, unless this is indexed to text volume, this value will not truly indicate whether presentation duration is appropriate, or the font readable. This finding highlights a potential issue with conferences mandating a predefined minimum period for display of CoI disclosures, as this does not take text size into account.

In addition to declaration slide duration, many presentations had additional aspects that made it more difficult for audience members to appreciate potential conflicts. Verbal acknowledgements of potential conflicts were present in fewer than half of presentations with CoI (n=5; 45%). Furthermore, a font size substantially smaller than the default was used in over half of those with CoI. To our knowledge, no study has analysed font size used to declare CoI. This novel finding highlights an opportunity to improve the quality of declarations, demonstrating that conference officials should ensure that a minimum font size is used by presenters.

Difficulty determining CoI declaration relevance is compounded by the fact that declarations occur at the start of the presentation, and audience members must recall presenter's declarations as potential conflicts arise through the talk. To counter this, presenters could display their declaration at the end of the presentation, as well as at the beginning. To our knowledge, no major conferences currently recommend this practice. Conflicts could also be submitted to a centralised system which auto-populates CoI slides for presenters ensuring appropriate formatting, or, in addition, CoI could also be placed in the conference programme or on-line with the speaker biography. Implementing a centralised system has been proposed by the Institute of Medicine and others.12,13 Such a system would address numerous issues, such as the burden on researchers to submit numerous individual declarations, the ambiguity surrounding what should be disclosed, and heterogenous nature of declarations. Fig 2 outlines what a suitable CoI declaration slide may look like, and includes a Quick Response (QR) code which could direct viewers to a centralised database to achieve this aim.

Fig 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig 2.

Example of a conflict of interest declaration with appropriate formatting and details.

Limitations

The aim of this study was to highlight the potential importance of additional factors when considering the appropriateness of conference CoI declarations. The main limitations of our study are the single conference assessed, the small number of CoI available for analysis, and the restriction to cardiology presentations. This may limit the external validity of this study's findings and should stimulate further consideration in other medical settings. This research used a pragmatic scoring system which requires further validation. The potential variables considered for this score were limited by the retrospective analysis of presentations. All variables were weighted equally in the scoring system; however, it is likely that some variables are more important than others when declaring conflicts. The weighting of variables and utility of this scoring system could be improved by validating it against a sample audience. This work is not able to comment on the nature of the conflicts declared, and whether they were relevant to their associated presentation. While the relevance of declarations is an important consideration, it was beyond the scope of this study. Finally, it should be noted that the ABPI Disclosure UK database does not give specific information regarding whether payments were received before or after their conference presentation in 2018.

Conclusions

This study demonstrates potential utility in considering aspects of CoI declarations at conferences other than display time. This work suggests that many CoI declarations at the conference studied are not fit for purpose. While applicability to other conferences/medical specialties is not certain, all conference organisers should consider what mechanisms are in place to ensure adequate quality of CoI disclosures. Further research into whether audiences are able to detect and remember potential CoI should be considered, paving the way for policies to mandate declarations of sufficient quality.

  • © Royal College of Physicians 2020. All rights reserved.

References

  1. ↵
    1. Dunn AG
    , Coiera E, Mandl KD, Bourgeois FT. Conflict of interest disclosure in biomedical research: a review of current practices, biases, and the role of public registries in improving transparency. Res Integr Peer Rev 2016;1:1.
    OpenUrl
  2. ↵
    1. Brax H
    , Fadlallah R, Al-Khaled L, et al. Association between physicians’ interaction with pharmaceutical companies and their clinical practices: A systematic review and meta-analysis. PLoS One 2017;12:e0175493.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Lundh A
    , Lexchin J, Mintzes B, Schroll JB, Bero L. Industry sponsorship and research outcome. Cochrane Database Syst Rev 2017;2:MR000033.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Hansen C
    , Lundh A, Rasmussen K, Hróbjartsson A. Financial conflicts of interest in systematic reviews: Associations with results, conclusions, and methodological quality. Cochrane Database Syst Rev 2019;8:MR000047.
    OpenUrl
  5. ↵
    1. Campbell E
    , Gruen R, Mountford J, et al. A national survey of physician–industry relationships. N Engl J Med 2007;356:1742–50.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Silverman E
    . Everything you need to know about the Sunshine Act. BMJ 2013;347:f4704.
    OpenUrlFREE Full Text
  7. ↵
    1. Adlington K
    , Godlee F. Disclosure UK: Transparency should no longer be an optional extra. BMJ 2016;354:i3730.
    OpenUrlFREE Full Text
  8. ↵
    1. Drazen JM
    , Van Der Weyden MB, Sahni P, et al. Uniform format for disclosure of competing interests in ICMJE journals. N Engl J Med 2009;361:1896–7.
    OpenUrlCrossRefPubMed
  9. ↵
    1. Grey A
    , Avenell A, Dalbeth N, Stewart F, Bolland MJ. Reporting of conflicts of interest in oral presentations at medical conferences: A delegate-based prospective observational study. BMJ Open 2017;7:e017019.
    OpenUrl
  10. ↵
    1. Van Lieshout CT
    , Tijdink JK, Smulders YM. Conflict of interest disclosure slides at the European Society of Cardiology Congress 2016 in Rome: Are they displayed long enough to assess their content? A cross-sectional study. BMJ Open 2018;8:e023534.
    OpenUrlAbstract/FREE Full Text
  11. ↵
    1. Taylor S
    . Eye movements in reading: facts and fallacies. Am Educ Research J 1965;2:187–202.
    OpenUrl
  12. ↵
    1. Lichter AS
    , McKinney R, Anderson T, et al. Harmonizing reporting on potential conflicts of interest: a common disclosure process for health care and life sciences: discussion paper. Washington: Institute of Medicine, 2012.
  13. ↵
    1. Lichter AS
    , McKinney R. Toward a harmonized and centralized conflict of interest disclosure. JAMA 2012;308:2093–4.
    OpenUrlCrossRefPubMed
View Abstract
Back to top
Previous articleNext article

Article Tools

Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Are conflict of interest declarations appropriate to allow sufficient consideration of potential bias in presentations?
William Crawford, C Fielder Camm, Ishika Prachee, Jack Olivarius-McAllister, Matthew R Ginks, Edward D Nicol
Future Healthc J Oct 2020, 7 (3) 226-229; DOI: 10.7861/fhj.2020-0018

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Are conflict of interest declarations appropriate to allow sufficient consideration of potential bias in presentations?
William Crawford, C Fielder Camm, Ishika Prachee, Jack Olivarius-McAllister, Matthew R Ginks, Edward D Nicol
Future Healthc J Oct 2020, 7 (3) 226-229; DOI: 10.7861/fhj.2020-0018
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • ABSTRACT
    • Introduction
    • Methods
    • Results
    • Discussion
    • Conclusions
    • References
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • The investigation and management of pancreatic exocrine insufficiency: A retrospective cohort study
  • Preceptorship scheme for newly qualified physician associates working in general practice in Sheffield
  • Distribution of contemporary sensitivity troponin in the emergency department and relationship to 30-day mortality: The CHARIOT-ED substudy
Show more Original research

Similar Articles

Navigate this Journal

  • Journal Home
  • Current Issue
  • Ahead of Print
  • Archive

Related Links

  • ClinMed - Home
  • FHJ - Home

Other Services

  • Advertising
futurehosp Footer Logo
  • Home
  • Journals
  • Contact us
  • Advertise
HighWire Press, Inc.

Follow Us:

  • Follow HighWire Origins on Twitter
  • Visit HighWire Origins on Facebook

Copyright © 2020 by the Royal College of Physicians